| 0 |
RED BLOOD CELL ACANTHOCYTES PRESENT |
2 |
0.1000 |
| 1 |
RED BLOOD CELL BURR CELLS PRESENT |
2 |
0.0444 |
| 2 |
MACROPHAGE ACTIVATION |
1 |
0.0294 |
| 3 |
NUCLEATED RED CELLS |
3 |
0.0268 |
| 4 |
PREALBUMIN DECREASED |
3 |
0.0250 |
| 5 |
VITAMIN A DECREASED |
3 |
0.0194 |
| 6 |
PORTAL TRACT INFLAMMATION |
2 |
0.0159 |
| 7 |
RED BLOOD CELL ELLIPTOCYTES PRESENT |
1 |
0.0130 |
| 8 |
URINARY CASTS PRESENT |
1 |
0.0095 |
| 9 |
BILIRUBIN URINE PRESENT |
1 |
0.0084 |
| 10 |
CREATININE URINE ABNORMAL |
1 |
0.0081 |
| 11 |
URINARY CASTS |
3 |
0.0077 |
| 12 |
PLATELET MORPHOLOGY ABNORMAL |
1 |
0.0073 |
| 13 |
URINARY OCCULT BLOOD POSITIVE |
1 |
0.0043 |
| 14 |
VITREOUS DISORDER |
2 |
0.0041 |
| 15 |
POLYCHROMASIA |
1 |
0.0033 |
| 16 |
URINARY SEDIMENT PRESENT |
2 |
0.0031 |
| 17 |
URINE LEUKOCYTE ESTERASE POSITIVE |
2 |
0.0029 |
| 18 |
PUNCTURE SITE HAEMORRHAGE |
2 |
0.0028 |
| 19 |
VITREOUS OPACITIES |
2 |
0.0024 |
| 20 |
NITRITE URINE PRESENT |
1 |
0.0023 |
| 21 |
RED BLOOD CELLS URINE POSITIVE |
2 |
0.0021 |
| 22 |
CRYSTAL URINE PRESENT |
1 |
0.0018 |
| 23 |
BACTERIAL TEST POSITIVE |
4 |
0.0018 |
| 24 |
BLEEDING TIME PROLONGED |
2 |
0.0017 |
| 25 |
URINE KETONE BODY PRESENT |
2 |
0.0013 |
| 26 |
PROTEIN URINE PRESENT |
5 |
0.0010 |
| 27 |
CORONAVIRUS TEST POSITIVE |
1 |
0.0010 |
| 28 |
URINE ABNORMALITY |
4 |
0.0009 |
| 29 |
HAEMATOCRIT INCREASED |
2 |
0.0009 |
| 30 |
SPEECH DISORDER DEVELOPMENTAL |
2 |
0.0007 |
| 31 |
URINE ANALYSIS ABNORMAL |
2 |
0.0007 |
| 32 |
WHITE BLOOD CELLS URINE POSITIVE |
1 |
0.0005 |
| 33 |
ALANINE AMINOTRANSFERASE ABNORMAL |
1 |
0.0005 |
| 34 |
OCULAR ICTERUS |
2 |
0.0005 |
| 35 |
LIPOMA |
1 |
0.0004 |
| 36 |
EOSINOPHIL COUNT INCREASED |
3 |
0.0004 |
| 37 |
BLOOD URIC ACID INCREASED |
2 |
0.0003 |
| 38 |
FINE MOTOR SKILL DYSFUNCTION |
1 |
0.0003 |
| 39 |
STRABISMUS |
1 |
0.0003 |
| 40 |
DYSCHEZIA |
1 |
0.0003 |
| 41 |
FUNCTIONAL GASTROINTESTINAL DISORDER |
1 |
0.0003 |
| 42 |
BLOOD CREATININE ABNORMAL |
1 |
0.0003 |
| 43 |
PROTEIN TOTAL DECREASED |
1 |
0.0003 |
| 44 |
SPLENOMEGALY |
3 |
0.0003 |
| 45 |
RENAL CYST |
2 |
0.0003 |
| 46 |
GLOMERULAR FILTRATION RATE DECREASED |
3 |
0.0002 |
| 47 |
VITREOUS FLOATERS |
2 |
0.0002 |
| 48 |
CORONARY ARTERY STENOSIS |
1 |
0.0002 |
| 49 |
BIPOLAR DISORDER |
2 |
0.0002 |
| 50 |
AUTISM SPECTRUM DISORDER |
1 |
0.0002 |
| 51 |
SOCIAL AVOIDANT BEHAVIOUR |
1 |
0.0002 |
| 52 |
CARDIAC PACEMAKER INSERTION |
1 |
0.0002 |
| 53 |
LARYNGEAL OEDEMA |
1 |
0.0002 |
| 54 |
HEPATITIS ACUTE |
1 |
0.0002 |
| 55 |
CARDIAC FAILURE ACUTE |
1 |
0.0001 |
| 56 |
MATERNAL EXPOSURE BEFORE PREGNANCY |
1 |
0.0001 |
| 57 |
DEFAECATION URGENCY |
1 |
0.0001 |
| 58 |
HEPATOCELLULAR INJURY |
2 |
0.0001 |
| 59 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
2 |
0.0001 |
| 60 |
CARDIAC OPERATION |
1 |
0.0001 |
| 61 |
LYMPHOCYTE COUNT DECREASED |
2 |
0.0001 |
| 62 |
LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR |
1 |
0.0001 |
| 63 |
GRAND MAL CONVULSION |
1 |
0.0001 |
| 64 |
RED BLOOD CELL COUNT DECREASED |
3 |
0.0001 |
| 65 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
3 |
0.0001 |
| 66 |
CHOLESTASIS |
2 |
0.0001 |
| 67 |
HAEMATOCRIT DECREASED |
2 |
0.0001 |
| 68 |
WEIGHT FLUCTUATION |
1 |
0.0001 |
| 69 |
FAECES DISCOLOURED |
2 |
0.0001 |
| 70 |
GASTROINTESTINAL PAIN |
1 |
0.0001 |
| 71 |
TRANSAMINASES INCREASED |
2 |
0.0001 |
| 72 |
CHROMATURIA |
2 |
0.0001 |
| 73 |
PLATELET COUNT DECREASED |
9 |
0.0001 |
| 74 |
POLYNEUROPATHY |
1 |
0.0001 |
| 75 |
HEPATITIS C |
1 |
0.0001 |
| 76 |
SCHIZOPHRENIA |
1 |
0.0001 |
| 77 |
MUSCLE SPASTICITY |
1 |
0.0001 |
| 78 |
SARS-COV-2 TEST POSITIVE |
1 |
0.0001 |
| 79 |
FREQUENT BOWEL MOVEMENTS |
2 |
0.0001 |
| 80 |
GINGIVAL BLEEDING |
1 |
0.0001 |
| 81 |
COGNITIVE DISORDER |
3 |
0.0001 |
| 82 |
BRAIN FOG |
1 |
0.0001 |
| 83 |
MOOD SWINGS |
2 |
0.0001 |
| 84 |
EYE DISORDER |
2 |
0.0001 |
| 85 |
MANIA |
1 |
0.0001 |
| 86 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
1 |
0.0001 |
| 87 |
PARANOIA |
1 |
0.0001 |
| 88 |
SYNOVITIS |
1 |
0.0001 |
| 89 |
HYPOCALCAEMIA |
1 |
0.0001 |
| 90 |
EAR PAIN |
1 |
0.0001 |
| 91 |
ACTIVITIES OF DAILY LIVING IMPAIRED |
1 |
0.0001 |
| 92 |
PRODUCT ADMINISTRATION ERROR |
1 |
0.0000 |
| 93 |
BODY TEMPERATURE INCREASED |
1 |
0.0000 |
| 94 |
INTENTIONAL DRUG MISUSE |
1 |
0.0000 |
| 95 |
RETCHING |
1 |
0.0000 |
| 96 |
IMPAIRED WORK ABILITY |
1 |
0.0000 |
| 97 |
INTERVERTEBRAL DISC PROTRUSION |
1 |
0.0000 |
| 98 |
CHILLS |
5 |
0.0000 |
| 99 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
2 |
0.0000 |
| 100 |
NEURALGIA |
1 |
0.0000 |
| 101 |
DRY EYE |
2 |
0.0000 |
| 102 |
HEPATITIS |
1 |
0.0000 |
| 103 |
THERAPY CESSATION |
2 |
0.0000 |
| 104 |
ASPARTATE AMINOTRANSFERASE INCREASED |
2 |
0.0000 |
| 105 |
EAR INFECTION |
1 |
0.0000 |
| 106 |
JAUNDICE |
1 |
0.0000 |
| 107 |
MENTAL STATUS CHANGES |
1 |
0.0000 |
| 108 |
WOUND |
1 |
0.0000 |
| 109 |
PRODUCT DOSE OMISSION IN ERROR |
1 |
0.0000 |
| 110 |
ACUTE MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 111 |
RESPIRATORY DISORDER |
1 |
0.0000 |
| 112 |
CONTRAINDICATED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 113 |
ALANINE AMINOTRANSFERASE INCREASED |
2 |
0.0000 |
| 114 |
NIGHT SWEATS |
1 |
0.0000 |
| 115 |
BLOOD CREATININE INCREASED |
2 |
0.0000 |
| 116 |
WHITE BLOOD CELL COUNT DECREASED |
3 |
0.0000 |
| 117 |
PANIC ATTACK |
1 |
0.0000 |
| 118 |
HALLUCINATION |
2 |
0.0000 |
| 119 |
PSORIATIC ARTHROPATHY |
1 |
0.0000 |
| 120 |
NEUTROPHIL COUNT DECREASED |
1 |
0.0000 |
| 121 |
RHABDOMYOLYSIS |
1 |
0.0000 |
| 122 |
ROAD TRAFFIC ACCIDENT |
1 |
0.0000 |
| 123 |
WITHDRAWAL SYNDROME |
1 |
0.0000 |
| 124 |
OSTEOARTHRITIS |
1 |
0.0000 |
| 125 |
RENAL FAILURE ACUTE |
1 |
0.0000 |
| 126 |
HYPOACUSIS |
1 |
0.0000 |
| 127 |
INTENTIONAL PRODUCT MISUSE |
2 |
0.0000 |
| 128 |
MUSCULOSKELETAL STIFFNESS |
2 |
0.0000 |
| 129 |
MATERNAL EXPOSURE DURING PREGNANCY |
2 |
0.0000 |
| 130 |
LOWER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 131 |
MEMORY IMPAIRMENT |
3 |
0.0000 |
| 132 |
HYPOKALAEMIA |
1 |
0.0000 |
| 133 |
RENAL DISORDER |
1 |
0.0000 |
| 134 |
ATRIAL FIBRILLATION |
2 |
0.0000 |
| 135 |
HAEMOGLOBIN DECREASED |
2 |
0.0000 |
| 136 |
ILLNESS |
2 |
0.0000 |
| 137 |
NERVOUSNESS |
1 |
0.0000 |
| 138 |
SPEECH DISORDER |
1 |
0.0000 |
| 139 |
DRUG INTERACTION |
3 |
0.0000 |
| 140 |
DISTURBANCE IN ATTENTION |
1 |
0.0000 |
| 141 |
OEDEMA |
1 |
0.0000 |
| 142 |
URTICARIA |
3 |
0.0000 |
| 143 |
HYPONATRAEMIA |
1 |
0.0000 |
| 144 |
CONVULSION |
1 |
0.0000 |
| 145 |
COVID-19 |
3 |
0.0000 |
| 146 |
NASAL CONGESTION |
1 |
0.0000 |
| 147 |
DISEASE PROGRESSION |
2 |
0.0000 |
| 148 |
NASOPHARYNGITIS |
3 |
0.0000 |
| 149 |
AMNESIA |
1 |
0.0000 |
| 150 |
BLOOD PRESSURE DECREASED |
1 |
0.0000 |
| 151 |
HYPOTENSION |
3 |
0.0000 |
| 152 |
VISION BLURRED |
2 |
0.0000 |
| 153 |
PRODUCT DOSE OMISSION ISSUE |
4 |
0.0000 |
| 154 |
DYSGEUSIA |
1 |
0.0000 |
| 155 |
HOT FLUSH |
1 |
0.0000 |
| 156 |
PRURITUS |
5 |
0.0000 |
| 157 |
PERIPHERAL SWELLING |
2 |
0.0000 |
| 158 |
ABDOMINAL PAIN |
3 |
0.0000 |
| 159 |
FATIGUE |
10 |
0.0000 |
| 160 |
FEELING ABNORMAL |
3 |
0.0000 |
| 161 |
CARDIAC FAILURE CONGESTIVE |
1 |
0.0000 |
| 162 |
GASTROOESOPHAGEAL REFLUX DISEASE |
1 |
0.0000 |
| 163 |
INFLUENZA LIKE ILLNESS |
1 |
0.0000 |
| 164 |
TREMOR |
2 |
0.0000 |
| 165 |
INTENTIONAL PRODUCT USE ISSUE |
1 |
0.0000 |
| 166 |
MALAISE |
5 |
0.0000 |
| 167 |
INSOMNIA |
3 |
0.0000 |
| 168 |
GASTROINTESTINAL DISORDER |
1 |
0.0000 |
| 169 |
OROPHARYNGEAL PAIN |
1 |
0.0000 |
| 170 |
CONTUSION |
1 |
0.0000 |
| 171 |
SOMNOLENCE |
2 |
0.0000 |
| 172 |
CHEST DISCOMFORT |
1 |
0.0000 |
| 173 |
SINUSITIS |
1 |
0.0000 |
| 174 |
ABDOMINAL DISTENSION |
1 |
0.0000 |
| 175 |
CONSTIPATION |
2 |
0.0000 |
| 176 |
INFLUENZA |
1 |
0.0000 |
| 177 |
THROMBOCYTOPENIA |
1 |
0.0000 |
| 178 |
WEIGHT INCREASED |
2 |
0.0000 |
| 179 |
DECREASED APPETITE |
2 |
0.0000 |
| 180 |
BACK PAIN |
2 |
0.0000 |
| 181 |
JOINT SWELLING |
1 |
0.0000 |
| 182 |
ASTHENIA |
3 |
0.0000 |
| 183 |
DIARRHOEA |
5 |
0.0000 |
| 184 |
ACUTE KIDNEY INJURY |
1 |
0.0000 |
| 185 |
VOMITING |
3 |
0.0000 |
| 186 |
HEADACHE |
4 |
0.0000 |
| 187 |
NAUSEA |
5 |
0.0000 |
| 188 |
DRUG DOSE OMISSION |
1 |
0.0000 |
| 189 |
DIZZINESS |
3 |
0.0000 |
| 190 |
MYALGIA |
1 |
0.0000 |
| 191 |
URINARY TRACT INFECTION |
1 |
0.0000 |
| 192 |
PYREXIA |
2 |
0.0000 |
| 193 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
1 |
0.0000 |
| 194 |
MUSCLE SPASMS |
1 |
0.0000 |
| 195 |
ALOPECIA |
1 |
0.0000 |
| 196 |
PAIN |
3 |
0.0000 |
| 197 |
ABDOMINAL PAIN UPPER |
1 |
0.0000 |
| 198 |
ARTHRALGIA |
2 |
0.0000 |
| 199 |
OVERDOSE |
1 |
0.0000 |
| 200 |
DEPRESSION |
1 |
0.0000 |
| 201 |
PRODUCT USE IN UNAPPROVED INDICATION |
1 |
0.0000 |
| 202 |
COUGH |
1 |
0.0000 |
| 203 |
DYSPNOEA |
2 |
0.0000 |
| 204 |
PAIN IN EXTREMITY |
1 |
0.0000 |
| 205 |
PNEUMONIA |
1 |
0.0000 |
| 206 |
RASH |
1 |
0.0000 |
| 207 |
OFF LABEL USE |
2 |
0.0000 |
| 208 |
DRUG INEFFECTIVE |
3 |
0.0000 |
| 209 |
DEATH |
1 |
0.0000 |